

Cover Story
COVID-19 & CancerGuest Editorial
By Jeremy L. Warner and Sanjay Mishra
As we head into the third year of the global COVID-19 pandemic, everyone would just like it to be over.
COVID-19 & Cancer
By Matthew Bin Han Ong, Alexandria Carolan and Alice Tracey
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Bhattacharya cancels NIH all-hands meeting
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - In the Headlines: “There’s no one to stand up for NCI right now.”
- George Weiner: Cancer centers are special, as are site visits in CCSG review